Latest Breaking News On - Aptose biosciences company profile - Page 1 : comparemela.com

Aptose Biosciences (NASDAQ:APTO) Coverage Initiated at StockNews com

Equities research analysts at StockNews.com started coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Several other analysts also recently commented on APTO. HC Wainwright reaffirmed a “buy” rating and set a $23.00 […]

United statesPiper sandlerAptose biosciencesAptose biosciences company profileCanaccord genuity groupAptose biosciences incTexas capital bank wealth management services incAnnandale capitalSigma planning corpGet free reportGenuity groupCapital bank wealth management services incBiosciences incAptose biosciences daily

Aptose Biosciences (TSE:APS) Hits New 1-Year Low at $1 36

Aptose Biosciences (TSE:APS) Hits New 1-Year Low at $1 36
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Aptose biosciencesAptose biosciences company profileAptose biosciences incGet free reportBiosciences stock downBiosciences incAptose biosciences daily

Aptose Biosciences (NASDAQ:APTO) Now Covered by Analysts at StockNews com

Investment analysts at StockNews.com initiated coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a report released on Wednesday. The firm set a “hold” rating on the biotechnology company’s stock. Other analysts also recently issued research reports about the company. Piper Sandler reaffirmed an “overweight” rating and issued a $5.00 price […]

United statesPiper sandlerAptose biosciencesSigma planning corpAptose biosciences incAptose biosciences company profileCanaccord genuity groupAnnandale capitalTexas capital bank wealth management services incGet free reportCapital bank wealth management services incBiosciences incAptose biosciences daily

Aptose Biosciences (NASDAQ:APTO) Price Target Lowered to $6 00 at Canaccord Genuity Group

Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) had its target price cut by Canaccord Genuity Group from $15.00 to $6.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Canaccord Genuity Group’s target price would suggest a potential upside of […]

United statesPiper sandlerAptose biosciencesAptose biosciences incTexas capital bank wealth management services incSigma planning corpAnnandale capitalCanaccord genuity groupAptose biosciences company profileGet free reportGenuity groupCapital bank wealth management services incBiosciences incAptose biosciences daily

Canaccord Genuity Group Trims Aptose Biosciences (NASDAQ:APTO) Target Price to $6 00

Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) had its price target dropped by equities researchers at Canaccord Genuity Group from $15.00 to $6.00 in a report released on Thursday, Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Canaccord Genuity Group’s price target would indicate a potential upside of […]

United statesAptose biosciencesPiper sandlerCanaccord genuity groupAnnandale capitalAptose biosciences company profileAptose biosciences incTexas capital bank wealth management services incSigma planning corpGet free reportGenuity groupCapital bank wealth management services incBiosciences incAptose biosciences daily